← Back to headlines
Curium to Acquire Lantheus in Up to $8 Billion Radiopharma Deal
Curium has announced an agreement to acquire radiopharmaceutical peer Lantheus for up to $8 billion, deepening its presence in the radiopharma sector. Separately, KKR is set to take medical equipment maker Integer Holdings private in a $5.7 billion deal.
3 Aug, 11:53 — 3 Aug, 15:29
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (59/100)5 sources33/33
Spectrum spread— 3/5 buckets covered17/33
Far L
Left2
Left (2)
Yahoocnbc
Center1
Center (1)
Reuters
Right2
Right (2)
wsjseeking-alpha
Far R
Geographic diversity— 2 regions9/34
US4Intl1
Sources
Showing 5 of 5 sources
ReutersVery High12d ago
KKR to take medical equipment maker Integer Holdings private in $5.7 billion deal - Reuters
KKR to take medical equipment maker Integer Holdings private in $5.7 billion deal Reuters
Read full article →wsjHigh12d ago
KKR to Buy Integer Holdings for $4.3 Billion in Cash - WSJ
KKR to Buy Integer Holdings for $4.3 Billion in Cash WSJ
Read full article →cnbcMostly Factual12d ago
Curium strikes up to $8 billion deal for radiopharma peer Lantheus
Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion, the companies said on Monday.
Read full article →YahooMostly Factual12d ago
Curium deepens radiopharma heft with up to $8 billion deal for Lantheus
Read full article →seeking-alphaMixed12d ago
Curium to buy Lantheus for up to $114.50/share in cash
Read full article →Coverage Timeline
First report: cnbc · 3 Aug, 11:53|Full coverage: 5 · 4h|Window: 4h
Left-leaningCenterRight-leaning
